Stryker reported 4Q21 orthopedic sales of $2.4 billion, +13.8% vs. 4Q20. For the full year of 2021, the company's orthopedic sales totaled $8.9 billion, +24.7% vs. 2020. We estimate Stryker's organic growth vs. 2019 was in the low single digits. The company's Mako robotic system remains a powerful growth driver as it approaches an install […]
Private investor clients of Connection Capital, the specialist private client investment business, have invested £6.7 million (~USD $9.4 million) in MatOrtho, to support its international growth and product development....
The underlying fundamentals of the orthopedic industry remain unchanged due to COVID-19. However, we should prepare for significant alterations in the market landscape as well as the ways that we interact with colleagues and customers.
What is the last exciting news you recall hearing about DePuy Synthes' knee franchise? Its competitors have dominated both industry news cycles and the market itself. Rajit Kamal, Vice President and Global Knee Franchise Leader at DePuy Synthes, aims to change that through a combination of hardware and technology.
Episurf Medical received an additional patent in China relative to the Episealer® Femoral Twin joint implant design process and expects to obtain CE Mark Approval for the Episealer Talus ankle implant.
Medacta and the Geisinger health system partnered to pilot a knee replacement lifetime guarantee, in which the pair will stand behind the full cost of care associated with surgeries over a patient's lifetime.
CyMedica Orthopedics' e-vive app-driven muscle strengthening device demonstrated statistically significant and positive results in a clinical trial evaluating the recovery of total knee replacement patients.
Clinical studies demonstrated that Stryker's Mako Total Knee was associated with less pain and need for opiates, shorter hospital stays, improved flexion and soft tissue protection vs. manual techniques.
ORTHOWORLD estimates see global knee joint replacement revenue growing in the low single digits for the coming years, approaching $10.5BB in 2022. Analysts suggest that 2019 will see a boost in growth based on factors such as broader release of robotic assistance technologies, effects from the removal of total knee replacement from the inpatient-only setting and episodic bundling for total joint procedures. Let's have a look at companies that have bolstered their knee lines with product launches from the past 12 months.
ORTHOWORLD expects the knee segment to remain a steady performer in the low single digits as price pressure erodes revenue from legacy products, but new technologies and products allow well-positioned companies to drive more favorable sales mix.
Dr. Bob Poggie reflects on trends in materials to increase durability of articulation and reliability of implant fixation; design solutions to improve kinematics; computer-driven advances in design and manufacturing and surgical tools to increase accuracy, reliability and efficiency of procedures.
Episurf Medical received another Notice of Allowance from the USPTO, addressing image segmentation used for 3D joint damage visualization as well as the design of patient-specific implants and instruments.
Zimmer Biomet and Apple have co-developed mymobility, an Apple Watch app designed to facilitate connection between hip and knee replacement patients and their surgical care teams. We believe that the announcement is indicative of forthcoming multi-industry digital health collaborations and products that will seek to shape orthopaedic care primarily in hip and knee recon.
The 1H18 performance of companies that make up ~80% of the joint reconstruction market achieved 4.1% growth vs. 1H17. These companies posted 2.4% growth in 1H17 vs. 1H16. Here is a look at past activity and future predictions for hip, knee and extremities.
Orthopaedic device manufacturers' ability to gain market share in the total knee and hip reconstruction spaces will be dependent upon their response to the shift of procedures to ambulatory surgery centers an uptick in bundled payments and any or all measures focused around cost. That was the message we took away from our conversations at the American Academy of Orthopaedic Surgeons Annual Meeting.
Study results suggest that patients who underwent medial-pivot TKA with MicroPort Orthopaedics' Evolution® system scored significantly better on the Forgotten Joint Score vs. posterior-stabilized knee recipients.
Study results suggest that use of ConforMI's iTotal CR Knee plus patient-specific instrumentation yields more consistent mechanical alignment than use of patient-specific cutting guides and off-the-shelf implants.